Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NumeralJSE:XII 20 OCF Margin % is 173.67% as of Feb. 2026. GuruFocus rates JSE:XII with a GF Score™ of 20/100. The stock has 7 warning signs investors should review. Among 961 Drug Manufacturers companies, Numeral ranks worse than 59.73% on this metric.
The historical data trend for Numeral's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:XII vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Numeral's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numeral OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Numeral's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Numeral's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numeral (JSE:XII) has a OCF Margin % of 173.67% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Numeral and its competitors. According to the industry distribution chart, Numeral ranks #574 out of 961 companies in the Drug Manufacturers industry, placing it in the top 59.7%.
Is Numeral's OCF Margin % too high?
Numeral's current OCF Margin % is 173.67%. The Drug Manufacturers industry median OCF Margin % is 9.77. Numeral's value of 173.67% is 1677.6% above this industry median. Based on the distribution chart, Numeral ranks #574 out of 961 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Numeral has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Numeral's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Numeral ranks #574 out of 961 companies for OCF Margin %. This places Numeral in the lower half of its industry. The industry median OCF Margin % is 9.77. Numeral's value of 173.67% is 1677.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.77, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Numeral's current OCF Margin % of 173.67% is 1677.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Numeral and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numeral's current OCF Margin % is 173.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numeral stock overvalued right now?
Numeral (JSE:XII) has a current OCF Margin % of 173.67%. The current OCF Margin % is 173.67% and 1677.6% above the Drug Manufacturers industry median of 9.77. Numeral's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Numeral (JSE:XII), the current OCF Margin % is 173.67% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numeral Ltd is an investment holding company based in Mauritius with a focus on fintech, biotechnology, and asset management. Geographically it has a presence in countries across Africa, Europe and Asia. The majority of its revenue is generated in the form of Trading income.
20GF Score
Get the complete analysis for JSE:XII
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:XII has been successfully added to your 
